Type 1 diabetes, rheumatoid arthritis, and cancer are just some of the disorders associated with specific genes not “turning on” and “turning off” as they should. By using new CRISPR/Cas9 genome...
U.S. government health officials approved the first new drug for Alzheimer's disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn't been...
Today Genome Quebec announced the results of its Genomic Integration Program, Human Health Stream competition. Five McGill teams from a diverse array of fields were awarded funds, totaling nearly ...
RSS